The mechanisms underlying immune dysregulation in MM are discussed, recent discoveries regarding immune remodeling associated with clinical outcomes are summarized, and the translational implications of immune-based biomarkers and therapeutic strategies are explored.
Maria P. Ghirardi, Patrícia Brandalise, M. Berraondo et al.· Immuno· 0 citations
Health Digital Twins (HDTs) have attracted increasing interest as a potential tool for improving both patient care and clinical research, particularly in oncology where clinical trials remain slow, costly, and operationally complex. This primer introduces the concept of digital twins in a form accessible to professiona...
Maria Garcia Requesens, Arun K. Mankan, Luca Cantini et al.· Frontiers in Oncology· 0 citations
A retrospective secondary analysis of comprehensive genomic and immune profiling data from 1737 patients with colorectal cancer tested showed that tumours arising in patients with EOCRC had lower tumour mutational burden than tumours diagnosed as LOCRC, whereas other immune-related biomarkers did not remain significant...
A. Nogueira, Jennifer Brondon, Konstantin Haradinov et al.· Oncology and Therapy· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.